Details about Tomas Philipson
Access statistics for papers by Tomas Philipson.
Last updated 2010-01-17. Update your information in the RePEc Author Service.
Short-id: pph37
Jump to Journal Articles Chapters
Working Papers
2017
- Sharing R&D Risk in Healthcare via FDA Hedges
NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
2016
- How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations
NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
2014
- Financial Health Economics
NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
- Health Care Adherence and Personalized Medicine
NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
2013
- Adjusting National Accounting for Health: Is the Business Cycle Countercyclical?
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
- Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension
NBER Working Papers, National Bureau of Economic Research, Inc
- International Health Economics
NBER Working Papers, National Bureau of Economic Research, Inc
2012
- Public Liabilities and Health Care Policy
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
2011
- Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets
NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)
2010
- Terminal Care and The Value of Life Near Its End
NBER Working Papers, National Bureau of Economic Research, Inc View citations (11)
- The Impact of Comparative Effectiveness Research on Health and Health Care Spending
NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
2009
- An Economic Evaluation of the War on Cancer
NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
- Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
NBER Working Papers, National Bureau of Economic Research, Inc View citations (21)
- The Effects of Product Liability Exemption in the Presence of the FDA
NBER Working Papers, National Bureau of Economic Research, Inc 
See also Chapter (2010)
2008
- Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity
NBER Working Papers, National Bureau of Economic Research, Inc View citations (32)
- The Value of Life in General Equilibrium
NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)
2007
- Integrated Insurance Design in the Presence of Multiple Medical Technologies
NBER Working Papers, National Bureau of Economic Research, Inc View citations (36)
See also Journal Article in American Economic Review (2007)
- Is the Food and Drug Administration Safe and Effective?
NBER Working Papers, National Bureau of Economic Research, Inc 
See also Journal Article in Journal of Economic Perspectives (2008)
- The Value of Life Near its End and Terminal Care
Levine's Working Paper Archive, David K. Levine View citations (11)
Also in NBER Working Papers, National Bureau of Economic Research, Inc (2007) View citations (10)
2006
- Antitrust in the Not-For-Profit Sector
NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)
Also in NBER Working Papers, National Bureau of Economic Research, Inc (2001) View citations (6)
See also Journal Article in Journal of Law and Economics (2009)
- Health Care, Technological Change, and Altruistic Consumption Externalities
NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)
- Intellectual Property and Marketing
NBER Working Papers, National Bureau of Economic Research, Inc View citations (9)
- Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
NBER Working Papers, National Bureau of Economic Research, Inc View citations (9)
Also in Public Economics, University Library of Munich, Germany (2005) View citations (2)
2005
- Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
- Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
See also Journal Article in Forum for Health Economics & Policy (2006)
2004
- Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
See also Journal Article in Forum for Health Economics & Policy (2005) Chapter (2005)
2003
- Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets
NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)
- The Quantity and Quality of Life and the Evolution of World Inequality
NBER Working Papers, National Bureau of Economic Research, Inc View citations (36)
See also Journal Article in American Economic Review (2005)
2002
- The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
NBER Working Papers, National Bureau of Economic Research, Inc View citations (17)
- The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the US
Working Papers, Harris School of Public Policy Studies, University of Chicago
- The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
Working Papers, Harris School of Public Policy Studies, University of Chicago View citations (17)
Also in NBER Working Papers, National Bureau of Economic Research, Inc (2002) View citations (210)
2000
- External Treatment Effects and Program Implementation Bias
NBER Technical Working Papers, National Bureau of Economic Research, Inc View citations (13)
Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (1999)
- Merit Motives and Government Intervention: Public Finance in Reverse
NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)
Also in University of Chicago - Population Research Center, Chicago - Population Research Center View citations (5)
1999
- Aging and the Growth of Long-Term Care
NBER Working Papers, National Bureau of Economic Research, Inc View citations (7)
Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (1999)
- Economic Epidemiology and Infectious Diseases
NBER Working Papers, National Bureau of Economic Research, Inc View citations (25)
See also Chapter (2000)
- The Long-Run Growth in Obesity as a Function of Technological Change
Working Papers, Harris School of Public Policy Studies, University of Chicago 
Also in NBER Working Papers, National Bureau of Economic Research, Inc (1999) View citations (115)
1998
- Data MArkets and OPtimal Sample Size Determination
DELTA Working Papers, DELTA (Ecole normale supérieure)
- Nonprofit Production and Competition
NBER Working Papers, National Bureau of Economic Research, Inc View citations (32)
- Pricing and R&D with Related Margins
DELTA Working Papers, DELTA (Ecole normale supérieure)
- The Rise in Old Age Longevity and the Market for Long-Term Care
NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
Also in University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State (1998) View citations (13)
See also Journal Article in American Economic Review (2002)
1997
- An Empirical Examination of Information Barriers to Trade inInsurance
University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations (5)
Also in NBER Working Papers, National Bureau of Economic Research, Inc (1996) View citations (10)
See also Journal Article in American Economic Review (1999)
- Consumption vs. Production of Insurance
NBER Working Papers, National Bureau of Economic Research, Inc
- Health investment complementarities under competing risks
Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra View citations (2)
- Observational Agency and Supply-Side Econometrics
NBER Technical Working Papers, National Bureau of Economic Research, Inc
- The Future of Old-Age Longevity: Competitive Pricing of Morality Contingent Claims
University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations (3)
Also in NBER Working Papers, National Bureau of Economic Research, Inc (1997) View citations (3)
1996
- Mortality Contingent Claims, Health Care, and Social Insurance
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
Also in University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State (1996) View citations (4)
- The Private Demand for Information and the Effects of Public Testing Programs: The Case of HIV
Working Papers, Yale - Economic Growth Center View citations (1)
1995
- Death, Tetanus and Aerobics: The Evaluation of Disease-Specific Health Interventions
CEPR Discussion Papers, C.E.P.R. Discussion Papers 
Also in Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra (1995)
- Disease Complementarities and the Evaluation of Public Health Interventions
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
- Disease Eradication: Private vs. Public Vaccination
DELTA Working Papers, DELTA (Ecole normale supérieure) View citations (1)
- Rational Epidemics and their Public Control
DELTA Working Papers, DELTA (Ecole normale supérieure)
See also Journal Article in International Economic Review (1996)
1994
- Will the AIDS Epidemic be Self-Limiting? Evidence on the Responsiveness of the Demand for Condoms to the Prevalence of AIDS
Working Papers, Harris School of Public Policy Studies, University of Chicago 
Also in University of Chicago - Population Research Center, Chicago - Population Research Center View citations (3)
Undated
- Estimating the Extent of Trade Under Incomplete Information: The Case of HIV
University of Chicago - Population Research Center, Chicago - Population Research Center
- Is Health Care Technology Over-Approved? A Meta-Analysis of Revealed Preference
University of Chicago - Population Research Center, Chicago - Population Research Center
- Nonprofit Production
University of Chicago - Population Research Center, Chicago - Population Research Center View citations (7)
- Self-Interested Treatment Evaluation in Experiments
University of Chicago - Population Research Center, Chicago - Population Research Center
Journal Articles
2009
- Antitrust in the Not-for-Profit Sector
Journal of Law and Economics, 2009, 52, (1), 1-18 View citations (18)
See also Working Paper (2006)
- `Me-Too' Innovation in Pharmaceutical Markets
Forum for Health Economics & Policy, 2009, 12, (1), 1-21 View citations (6)
See also Chapter (2009)
2008
- Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
Journal of Public Economics, 2008, 92, (5-6), 1306-1325 View citations (8)
- Cost-effectiveness analysis and innovation
Journal of Health Economics, 2008, 27, (5), 1224-1236 View citations (24)
- Is the Food And Drug Administration Safe And Effective?
Journal of Economic Perspectives, 2008, 22, (1), 85-102 View citations (9)
See also Working Paper (2007)
- Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy
Journal of Economic Literature, 2008, 46, (4), 974-82 View citations (27)
2007
- Integrated Insurance Design in the Presence of Multiple Medical Technologies
American Economic Review, 2007, 97, (2), 427-432 View citations (38)
See also Working Paper (2007)
- Labor Supply and Weight
Journal of Human Resources, 2007, 42, (1) View citations (55)
- The institute of medicine report on the FDA: where is the science?
Health Economics, 2007, 16, (3), 219-221
2006
- The nonprofit sector and industry performance
Journal of Public Economics, 2006, 90, (8-9), 1681-1698 View citations (98)
- Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
Forum for Health Economics & Policy, 2006, 9, (2), 1-33 View citations (22)
See also Working Paper (2005)
2005
- Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
Forum for Health Economics & Policy, 2005, 8, (1), 1-25 
See also Chapter (2005) Working Paper (2004)
- The Quantity and Quality of Life and the Evolution of World Inequality
American Economic Review, 2005, 95, (1), 277-291 View citations (374)
See also Working Paper (2003)
- Welfare-Enhancing Technological Change and the Growth of Obesity
American Economic Review, 2005, 95, (2), 253-257 View citations (127)
2002
- Pricing and R&D When Consumption Affects Longevity
RAND Journal of Economics, 2002, 33, (1), 85-95
- The Rise in Old-Age Longevity and the Market for Long-Term Care
American Economic Review, 2002, 92, (1), 295-306 View citations (47)
See also Working Paper (1998)
2001
- Data Markets, Missing Data, and Incentive Pay
Econometrica, 2001, 69, (4), 1099-1111 View citations (12)
- Managed Care and the Quality of Health Care: A Misguided Debate?
The Journal of Legal Studies, 2001, 30, (2), 753-58
- Public Financing and the Market for Long-Term Care
Forum for Health Economics & Policy, 2001, 4, (1), 1-19 
See also Chapter (2001)
- The world‐wide growth in obesity: an economic research agenda
Health Economics, 2001, 10, (1), 1-7 View citations (84)
1999
- An Empirical Examination of Information Barriers to Trade in Insurance
American Economic Review, 1999, 89, (4), 827-846 View citations (183)
See also Working Paper (1997)
- Longevity Complementarities under Competing Risks
American Economic Review, 1999, 89, (5), 1358-1371 View citations (50)
- Measurement errors: A principal investigator-agent approach
Journal of Econometrics, 1999, 91, (2), 273-298 View citations (12)
1998
- Old-Age Longevity and Mortality-Contingent Claims
Journal of Political Economy, 1998, 106, (3), 551-573 View citations (104)
- Subject Evaluation in Social Experiments
Econometrica, 1998, 66, (2), 381-408 View citations (13)
1997
- Disease Eradication: Private versus Public Vaccination
American Economic Review, 1997, 87, (1), 222-30 View citations (89)
- Multiple-output agency incentives in data production: experimental evidence
European Economic Review, 1997, 41, (3-5), 961-970 View citations (1)
- The evaluation of new health care technology: The labor economics of statistics
Journal of Econometrics, 1997, 76, (1-2), 375-395 View citations (4)
1996
- An empirical examination of the implications of assortative matching on the incidence of HIV
Journal of Health Economics, 1996, 15, (6), 735-749 View citations (4)
- Equilibrium and Efficiency in an Organized Vote Market
Public Choice, 1996, 89, (3-4), 245-65 View citations (25)
- Rational Epidemics and Their Public Control
International Economic Review, 1996, 37, (3), 603-24 View citations (97)
See also Working Paper (1995)
- The Economic Epidemiology of Crime
Journal of Law and Economics, 1996, 39, (2), 405-33 View citations (28)
1995
- The welfare loss of disease and the theory of taxation
Journal of Health Economics, 1995, 14, (3), 387-395 View citations (7)
1994
- Public Spending on AIDS Education: An Economic Analysis
Journal of Law and Economics, 1994, 37, (1), 17-38 View citations (10)
1993
- Social Welfare and Measurement of Segregation
Journal of Economic Theory, 1993, 60, (2), 322-334 View citations (9)
1991
- Dynamic information release
Journal of Economics, 1991, 53, (2), 205-213
Chapters
2018
- The Economic Value and Pricing of Personalized Medicine
A chapter in Economic Dimensions of Personalized and Precision Medicine, 2018, pp 9-19
2010
- The Effects of Product Liability Exemption in the Presence of the FDA
A chapter in Regulation vs. Litigation: Perspectives from Economics and Law, 2010, pp 137-163 View citations (3)
See also Working Paper (2009)
2009
- "Me-Too" Innovation in Pharmaceutical Markets
A chapter in Frontiers in Health Policy Research, volume 12, 2009 View citations (3)
See also Journal Article in Forum for Health Economics & Policy (2009)
2005
- Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
A chapter in Frontiers in Health Policy Research, Volume 8, 2005
See also Journal Article in Forum for Health Economics & Policy (2005) Working Paper (2004)
2003
- Theories of Firm Behavior in the Nonprofit Sector. A Synthesis and Empirical Evaluation
A chapter in The Governance of Not-for-Profit Organizations, 2003, pp 181-216 View citations (34)
2001
- Medical Care Output and Productivity in the Nonprofit Sector
A chapter in Medical Care Output and Productivity, 2001, pp 119-140 View citations (1)
- Public Financing and the Market for Long-Term Care
A chapter in Frontiers in Health Policy Research, Volume 4, 2001, pp 77-94 
See also Journal Article in Forum for Health Economics & Policy (2001)
2000
- Asymmetric Information and the Not-for-Profit Sector Does Its Output Sell a a Premium?
A chapter in The Changing Hospital Industry: Comparing Not-for-Profit and For-Profit Institutions, 2000, pp 325-356 View citations (3)
- Economic epidemiology and infectious diseases
Chapter 33 in Handbook of Health Economics, 2000, vol. 1, pp 1761-1799 View citations (59)
See also Working Paper (1999)
|
The links between different versions of a paper are constructed automatically by matching on the titles.
Please contact if a link is incorrect.
Use this form
to add links between versions where the titles do not match.
|